{"id":133645,"name":"IMPRIMIS PHARMACEUTICALS, INC.","slug":"imprimis-pharmaceuticals-inc","state":"CA","country":"United States of America","description":"Pharmaceutical Company","totalSpending":390000,"filings":8,"yearlySpending":[{"year":2018,"income":240000},{"year":2019,"income":150000}],"issues":[{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["MORGAN, LEWIS & BOCKIUS, LLP"],"lobbyists":["CHRIS COX"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)","Office of Management & Budget (OMB)","Office of the Vice President of the United States"],"sampleDescriptions":["Opportunities for Medicare and patient savings through innovation.","Proposal for legislation to reduce prescription drug prices on proprietary compounded ophthalmic formulations.","Opportunities to reduce prescription drug prices through competition.","Strategies to reduce prescription drug prices and Medicare costs","Strategies to reduce prescription drug prices and Medicare costs"]}